Ontario man says medication he's been taking for a decade just quadrupled in price
An Ontario man with Duchenne muscular dystrophy said he was shocked when he got his latest prescription filled for a medication he has been taking for the past ten years.
“I couldn’t believe it. I need to take this medication to help my muscles be able to work a bit better and it has almost quadrupled in price,” said 21-year-old Arun Crishanth of Aurora.
The medication is Deflazacort, a popular drug used to treat Duchenne muscular dystrophy, however it is not covered under government health plans.
The drug is a steroid taken daily to help keep muscles strong and symptoms of muscular dystrophy in check.
Crishanth said he used to get a four month supply of Deflazacort for $187, but when he got his last prescription filled it jumped to $666.
Crishanth was told by his pharmacy Pharmasave that the price increase was due to it being manufactured by a new drug company.
“This new company decided to turn around and quadruple the price. To me it seems ridiculous that they can increase the price that much," said Crishanth.
CTV News Toronto reached out to Pharmasave and a spokesperson said, “Pharmacy pricing in Canada is linked to the cost to purchase the medication from the manufacturer or distributor. The increased pricing experienced by pharmacies (and thus also to patients) is due to manufacturer and distributor changes.”
Deflazacort, a popular drug used to treat Duchenne muscular dystrophy, is photographed. CTV News Toronto also reached out to Muscular Dystrophy Canada and its CEO Stacey Lintern said in a statement, “Many individuals and their families have been advised by their doctors that Deflazacort is the most suitable option due to its minimal side effects, with some individuals having been on this treatment for 15 years or more. However, the significant increase in price will have detrimental effects on these individuals and their families.”
CTV News Toronto was unable to reach the new manufacturer of Deflazacourt, however Muscular Dystrophy Canada confirmed the price increase was due to a new manufacturer making the drug in Europe which also means increased shipping costs.
While there are cheaper alternatives, they have side effects and many patients with Duchenne muscular dystrophy feel that Deflazacourt is the preferred treatment.
"It’s a drug I’ve been taking for so many years, since I was 10 years old," said Crishanth, who said the drug will now cost him almost $2,000 a year.
"Obviously they should not be able to increase prices like that. It clearly isn't because of inflation, this is just to make some money and I think it's ridiculous that that can happen," said Crishanth.
Muscular Dystrophy Canada said it's important for patients to have equal access to appropriate treatments at a fair cost and that they will continue to try and influence change with regards to the price hike.
If you or your child is experiencing challenges accessing Deflazacort, you can contact Muscular Dystrophy Canada at research@muscle.ca or call 1-800-567-2873 ext. 1114.
CTVNews.ca Top Stories
Syrian rebels topple Assad, transforming nation and Middle East
Syria rebel fighters raced into Damascus unopposed on Sunday, overthrowing President Bashar al-Assad and ending nearly six decades of his family's iron-fisted rule after a lightning advance that reversed the course of a 13-year civil war.
Baby found dead in south Edmonton parking lot: police
Police are investigating the death of an infant in south Edmonton.
Trump calls for immediate cease-fire in Ukraine and says a U.S. withdrawal from NATO is possible
Donald Trump on Sunday pushed Russian leader Vladimir Putin to act to reach an immediate ceasefire with Ukraine, describing it as part of his active efforts as U.S. president-elect to end the war despite being weeks from taking office.
A man, a bike and a gun: Police search for evidence to solve the killing of UnitedHealthcare’s CEO on the streets of New York
As the investigation into the fatal shooting of a health care executive in Manhattan enters its fifth day, New York City police are missing key pieces of evidence.
Updated advisory urges Canadians to avoid all travel to Syria, leave if possible
Ottawa is urging Canadians to avoid all travel to Syria and to consider leaving the country if it's safe to do so.
Trump says he can't guarantee tariffs won't raise U.S. prices and promises swift immigration action
Donald Trump said he can't guarantee that his promised tariffs on key U.S. foreign trade partners won't raise prices for American consumers and he suggested once more that some political rivals and federal officials who pursued legal cases against him should be imprisoned.
After $80 million Lotto Max, another lucky Lotto 6/49 ticket sold in Quebec
Lotto-Québec announced on Sunday that "the classic jackpot of $5 million, offered in yesterday's (Saturday) Lotto 6/49 draw, was won thanks to a ticket sold in Quebec."
MP Jamil Jivani meets U.S. vice president-elect amid Trump's tariff threats
A Conservative member of Parliament has tapped a longtime friendship to connect with Donald Trump's inner circle as Canada prepares for the president-elect’s return to the White House next month amid threats of devastating tariffs.
Canada 'falling so consistently short' on defence spending has hurt standing on world stage, but improving: U.S. ambassador
U.S. Ambassador to Canada David Cohen says while Canada's defence spending is going in the right direction, the federal government's persistent failure to meet NATO targets has been damaging to the country's reputation on the world stage.